Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 30 studies | 33% ± 18% | |
smooth muscle cell | 11 studies | 22% ± 5% | |
fibroblast | 7 studies | 24% ± 9% | |
astrocyte | 7 studies | 36% ± 14% | |
endothelial cell | 5 studies | 27% ± 5% | |
cardiac muscle cell | 5 studies | 31% ± 9% | |
type II pneumocyte | 5 studies | 25% ± 5% | |
adipocyte | 4 studies | 20% ± 2% | |
hepatocyte | 3 studies | 48% ± 22% | |
muscle cell | 3 studies | 44% ± 24% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 3 studies | 24% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3215.06 | 457 / 459 | 88% | 3.62 | 979 / 1118 |
lung | 97% | 1765.25 | 561 / 578 | 84% | 4.09 | 968 / 1155 |
liver | 100% | 3645.36 | 226 / 226 | 78% | 5.34 | 316 / 406 |
prostate | 92% | 1572.53 | 226 / 245 | 84% | 3.52 | 420 / 502 |
thymus | 99% | 2368.97 | 648 / 653 | 70% | 1.95 | 421 / 605 |
adrenal gland | 79% | 912.84 | 205 / 258 | 74% | 5.17 | 170 / 230 |
brain | 54% | 585.57 | 1427 / 2642 | 95% | 5.68 | 667 / 705 |
ovary | 98% | 2113.12 | 177 / 180 | 50% | 1.99 | 213 / 430 |
esophagus | 75% | 2878.70 | 1090 / 1445 | 69% | 2.93 | 127 / 183 |
bladder | 100% | 1715.52 | 21 / 21 | 37% | 1.16 | 186 / 504 |
pancreas | 47% | 421.66 | 153 / 328 | 87% | 5.19 | 155 / 178 |
uterus | 99% | 4812.47 | 169 / 170 | 29% | 2.23 | 134 / 459 |
skin | 78% | 2027.89 | 1414 / 1809 | 49% | 1.64 | 233 / 472 |
kidney | 42% | 758.12 | 37 / 89 | 80% | 6.29 | 719 / 901 |
intestine | 74% | 1730.89 | 717 / 966 | 41% | 1.48 | 214 / 527 |
stomach | 54% | 2378.15 | 194 / 359 | 60% | 3.61 | 172 / 286 |
adipose | 100% | 4574.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 6620.38 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 3783.77 | 858 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 2746.87 | 1294 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 49% | 1.10 | 22 / 45 |
spleen | 49% | 476.05 | 117 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.39 | 6 / 29 |
eye | 0% | 0 | 0 / 0 | 6% | 0.11 | 5 / 80 |
peripheral blood | 0% | 4.35 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0098656 | Biological process | monoatomic anion transmembrane transport |
GO_0055085 | Biological process | transmembrane transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0033198 | Biological process | response to ATP |
GO_0051607 | Biological process | defense response to virus |
GO_0060976 | Biological process | coronary vasculature development |
GO_0086003 | Biological process | cardiac muscle cell contraction |
GO_0098662 | Biological process | inorganic cation transmembrane transport |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0045776 | Biological process | negative regulation of blood pressure |
GO_0098655 | Biological process | monoatomic cation transmembrane transport |
GO_0048144 | Biological process | fibroblast proliferation |
GO_0061337 | Biological process | cardiac conduction |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0001508 | Biological process | action potential |
GO_0003007 | Biological process | heart morphogenesis |
GO_1990573 | Biological process | potassium ion import across plasma membrane |
GO_0031004 | Cellular component | potassium ion-transporting ATPase complex |
GO_0008282 | Cellular component | inward rectifying potassium channel |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0030017 | Cellular component | sarcomere |
GO_0140359 | Molecular function | ABC-type transporter activity |
GO_0043225 | Molecular function | ATPase-coupled inorganic anion transmembrane transporter activity |
GO_0019829 | Molecular function | ATPase-coupled monoatomic cation transmembrane transporter activity |
GO_0005261 | Molecular function | monoatomic cation channel activity |
GO_0015459 | Molecular function | potassium channel regulator activity |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005267 | Molecular function | potassium channel activity |
GO_0008281 | Molecular function | sulfonylurea receptor activity |
GO_0042626 | Molecular function | ATPase-coupled transmembrane transporter activity |
GO_0022857 | Molecular function | transmembrane transporter activity |
GO_0015272 | Molecular function | ATP-activated inward rectifier potassium channel activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | ABCC9 |
Protein name | ABCC9 protein (ATP binding cassette subfamily C member 9) ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) ATP binding cassette subfamily C member 9 (ATP-binding cassette, sub-family C (CFTR/MRP), member 9, isoform CRA_a) ATP binding cassette subfamily C member 9 |
Synonyms | hCG_24790 SUR2 |
Description | FUNCTION: Subunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with KCNJ11. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation. . |
Accessions | ENST00000684435.1 ENST00000261200.9 [O60706-2] A0A804HL58 ENST00000621589.2 A0A7R6M6Q9 A0A804HK56 G3V1N6 H0YFV4 ENST00000326684.8 Q8N4N7 A0A804HL22 ENST00000682879.1 A0A804HIU2 A0A7R6M6P9 ENST00000682068.1 A0A804HHX2 O60706 ENST00000683105.1 ENST00000683676.1 A0A804HKB7 ENST00000538350.5 ENST00000544039.5 ENST00000261201.10 [O60706-1] ENST00000684084.1 ENST00000636888.1 A0A7R6M6P4 |